Literature DB >> 27018336

Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.

Hong Lang1, Chun Dai2.   

Abstract

BACKGROUND AND AIMS: We undertook this study to observe the effects of bone marrow mesenchymal stem cells (BMSCs) on plasminogen activator inhibitor-1 (PAI-1) and renal fibrosis in rats with diabetic nephropathy and to explore its main mechanism.
METHODS: Thirty male Sprague Dawley rats were randomly divided into three groups: normal control group (NC group, n = 10), diabetic nephropathy group (DN group, n = 10), stem cell transplantation group (MSC group, n = 10). BMSCs were transplanted to rats in the MSC group via caudal vein infusion (2 × 10(6)/mL). At the end of 12 weeks, blood glucose, 24-h urinary protein, serum creatinine and renal mass index were measured. Morphology and collagen deposition in rat kidney were observed by HE and Masson staining, respectively. Expressions of PAI-1, transforming growth factor β1 (TGF-β1) and Smad3 in rat kidney were detected by immunohistochemistry and Western blot.
RESULTS: Compared with DN group, 24-h protein, serum creatinine and renal mass index decreased significantly in MSC group. No significant changes in blood glucose (p >0.05) were shown. Immunohistochemistry and Western blot showed that expressions of PAI-1, TGF-β1 and Smad3 in NC group were lower than DN group. Expression of each protein in MSC group was between two groups (p <0.05). Correlation analysis revealed that PAI-1 and TGF-β1 (r = 0.987, p <0.05) and Smad3 (r = 0.974, p <0.05) showed a significant positive correlation. TGF-β1 and Smad3 (r = 0.962, p <0.05) were positively correlated.
CONCLUSIONS: BMSCs significantly inhibited renal fibrosis in rats with DN. The mechanism may be related to inhibition of TGF-β1/Smad3 pathway, decreasing the expression of PAI-1 protein and reducing the accumulation of extracellular matrix, thereby balancing the fibrinolytic system.
Copyright © 2016 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow mesenchymal stem cells; Diabetic nephropathy; Plasminogen activator inhibitor-1; Renal fibrosis; Transforming growth factor-β1/Smad3 signaling pathway

Mesh:

Substances:

Year:  2016        PMID: 27018336     DOI: 10.1016/j.arcmed.2016.03.002

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  18 in total

Review 1.  Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence.

Authors:  Yuexin Zhu; Manyu Luo; Xue Bai; Yan Lou; Ping Nie; Shan Jiang; Jicui Li; Bing Li; Ping Luo
Journal:  Mol Cell Biochem       Date:  2022-04-25       Impact factor: 3.396

Review 2.  Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy.

Authors:  Janaina Paulini; Eliza Higuti; Rosana M C Bastos; Samirah A Gomes; Érika B Rangel
Journal:  Stem Cells Int       Date:  2016-12-13       Impact factor: 5.443

3.  Sustained kidney biochemical derangement in treated experimental diabetes: a clue to metabolic memory.

Authors:  Antonio Anax F de Oliveira; Tiago F de Oliveira; Larissa L Bobadilla; Camila C M Garcia; Carolina Maria Berra; Nadja C de Souza-Pinto; Marisa H G Medeiros; Paolo Di Mascio; Roberto Zatz; Ana Paula de M Loureiro
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

4.  Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells.

Authors:  Xin Wang; Jun-Ling Gao; Man-Man Zhao; Hui-Xing Zhu; Yan-Xia Tian; Ran Li; Xiao-Hua Jiang; Lei Yu; Jing-Rui Tian; Jian-Zhong Cui
Journal:  Int J Mol Med       Date:  2017-11-24       Impact factor: 4.101

5.  Mechanistic insights into the augmented effect of bone marrow mesenchymal stem cells and thiazolidinediones in streptozotocin-nicotinamide induced diabetic rats.

Authors:  Alaaeldin Ahmed Hamza; Ebtehal Mohammad Fikry; Wedad Abdallah; Amr Amin
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

6.  Nephroprotective Potential of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Murine Model of Chronic Cyclosporine Nephrotoxicity.

Authors:  María José Ramírez-Bajo; Javier Martín-Ramírez; Stefania Bruno; Chiara Pasquino; Elisenda Banon-Maneus; Jordi Rovira; Daniel Moya-Rull; Marta Lazo-Rodriguez; Josep M Campistol; Giovanni Camussi; Fritz Diekmann
Journal:  Front Cell Dev Biol       Date:  2020-05-05

Review 7.  Concise review: current trends on applications of stem cells in diabetic nephropathy.

Authors:  Dongwei Liu; Wen Zheng; Shaokang Pan; Zhangsuo Liu
Journal:  Cell Death Dis       Date:  2020-11-21       Impact factor: 8.469

Review 8.  Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis.

Authors:  Yiping Liu; Yan-Yan Su; Qian Yang; Tianbiao Zhou
Journal:  Stem Cell Res Ther       Date:  2021-06-10       Impact factor: 6.832

9.  An additive effect of anti-PAI-1 antibody to ACE inhibitor on slowing the progression of diabetic kidney disease.

Authors:  Chunyan Gu; Jiandong Zhang; Nancy A Noble; Xiao-Rong Peng; Yufeng Huang
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-10

Review 10.  Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.

Authors:  Adriana Torres Crigna; Cristina Daniele; Carolina Gamez; Sara Medina Balbuena; Diego O Pastene; Daniela Nardozi; Cinzia Brenna; Benito Yard; Norbert Gretz; Karen Bieback
Journal:  Front Med (Lausanne)       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.